康涅狄格州吉尔福德 - 医疗技术先驱Hyperfine, Inc. (NASDAQ:HYPR)宣布其最新的Swoop®系统软件获得CE认证。根据欧洲医疗器械法规获得的这一认证是该公司在欧洲扩张的关键一步，使其便携式磁共振 (MR)脑成像系统能够更广泛地商业化推广。

Hyperfine secured initial CE certification for the Swoop ® system in 2023. Earlier this year, Hyperfine significantly ...

马德里 - Hyperfine, Inc. (NASDAQ:HYPR) 在临床试验阿尔茨海默病（CTAD）会议上展示了新的研究数据，证明其Swoop® Portable MR Imaging®系统在监测阿尔茨海默病患者方面的潜力。这项由圣路易斯华盛顿大学进行的研究利用Swoop®系统检测接受Lecanemab治疗的患者中的淀粉样蛋白相关成像异常（ARIA-E）。 Swoop®系统是一款经FDA批准 ...

Hyperfine, Inc. announced the presentation of additional research data and images using the Swoop® system to image patients with Alzheimer’s disease.

Hyperfine (HYPR) announced the presentation of additional research data and images using the Swoop system to image patients with ...

MADRID, October 31, 2024--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable ...

MADRID, October 31, 2024--Hyperfine, Inc. announced the presentation of additional research data and images using the Swoop® system to image patients with Alzheimer’s disease. GUILFORD ...

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic ...

Hyperfine plans to roll out the updated Swoop system software in the coming months. Market Prospects Going by a Grand View Research report, the global MRI was valued at $5.26 billion in 2022.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

MADRID - Hyperfine, Inc. (NASDAQ:HYPR) has presented new research data at the Clinical Trials on Alzheimer's Disease (CTAD) conference, demonstrating the potential of its Swoop® Portable MR ...